PRU

Prudential Financial, Inc.

NYSE • USD • FINANCIAL SERVICES • INSURANCE - LIFE

Current Price $97.65 6 Months: -7.04%

52-Week Range

$91.89 $119.76

Current price is 20.7% of 52-week range

Key Metrics

Market Cap $35.4B
P/E Ratio N/A
Current Ratio N/A
EPS
Dividend Yield N/A
ATR(14) $2.38
Beta 0.9
PEG Ratio N/A
ROE N/A
Operating Earnings Growth Rate 201.65%

AI Overview

Last updated 17 days ago

Prudential Financial is a scaled, diversified insurer and retirement provider with a meaningful asset-management franchise (PGIM), which helps balance spread-based earnings with fee revenues. Its mix of U.S. Group Insurance, Retirement strategies, and international operations supports persistence and cross-selling, but results remain sensitive to market levels, credit conditions, and assumption updates typical for large life insurers. A strategic partnership effort with Dai-ichi Life in Japan could strengthen distribution and asset-management reach, though execution matters.

Financially, PRU generated 2025 net income attributable to common of $3.576B ($9.99/share) and 4Q25 EPS of $2.55, while after-tax adjusted operating income in 4Q25 was $3.30/share; full-year 2025 adjusted operating income per share was about $14.43. Trailing revenue is roughly $61.2B, ROE about 11.4%, and total assets were about $773.7B at 12/31/2025; valuation looks undemanding at ~10x trailing EPS with a high dividend (recently ~$5.60 annualized, ~5.6% yield) but leverage and capital-market sensitivity are key watch items. AUM/AUA was about $1.7T as of early 2025, underscoring fee scale but also equity/bond-market exposure.

Over the next 12 months, the thesis is a “carry + capital return” story: investors are paid to wait via a ~5%+ yield while operating earnings and buybacks can compound if credit and rates remain supportive. Catalysts include the May 5, 2026 earnings report (capital, credit, and spread trends), sustained private credit/alternatives flows at PGIM, and any tangible progress on Japan distribution. Key risks are widening credit spreads/defaults, adverse mortality/morbidity, and mark-to-market or assumption changes that pressure capital and sentiment.

Recommendation: HOLD. The dividend and low multiple are attractive, but earnings and valuation can stay capped until investors see steadier capital generation and less sensitivity to macro and credit outcomes.

Price & Profitability History

6 Months change: -7.04% (-$7.39)

Log in